Abeona Therapeutics (ABEO) Interest Coverage Ratio Growth (5y) (2016 - 2026)
Abeona Therapeutics (ABEO) Interest Coverage Ratio Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.55% |
| Dec 31, 2025 | 33.39% |
| Sep 30, 2025 | -29.02% |
| Jun 30, 2025 | -9.43% |
| Mar 31, 2025 | 19.29% |
| Dec 31, 2024 | 51.70% |
| Sep 30, 2024 | -20.01% |
| Jun 30, 2024 | -44.93% |
| Mar 31, 2024 | -15.18% |
| Dec 31, 2023 | -14.38% |
| Sep 30, 2023 | 29.90% |
| Jun 30, 2023 | 18.14% |
| Mar 31, 2023 | 46.57% |
| Dec 31, 2022 | 61.64% |
| Sep 30, 2022 | -22.69% |
| Jun 30, 2022 | 50.17% |
| Mar 31, 2022 | -7.92% |
| Dec 31, 2021 | 19.91% |
| Sep 30, 2021 | -74.36% |
| Jun 30, 2021 | 4.55% |